Found 1227 clinical trials
Neoadjuvant Chemotherapy in Borderline Resectable and Locally Advanced Pancreatic Cancer
This is a Norwegian prospective observational study that evaluates the resectability rate in patients with borderline resectable and locally advanced pancreatic cancer who received neoadjuvant chemotherapy in a population based cohort. Eligible patients are treated with neoadjuvant chemotherapy possibly followed by surgical exploration and resection.
- 0 views
- 16 Feb, 2024
- 1 location
A Longitudinal Observational Biomarker Study in Pancreatic Cancer Patients Receiving Chemotherapy
Based on the literature, the pancreatic cancer treatment predictor biomarker, which is used in the domestic clinical field, is actually applied to the pancreatic cancer patient cohort of the National Cancer Center.
- 0 views
- 16 Feb, 2024
- 1 location
A Study of the Life Changes Experienced by Patients With Pancreatic Cancer
The purpose of this study is to better understand what types of transitions people with pancreatic cancer face when they receive chemotherapy. Again, this study defines transition as a change in a life situation or a status that causes a change in a person's identity, role, behavior, or personal relationships.
- 0 views
- 05 Aug, 2020
The Role of MicroRNA in the Diagnosis Prognosis and Response to Treatment in Pancreatic Cancer
We hypothesize that the detection of certain miRNAs present in the blood/serum of patients with pancreatic cancer may be important to the early diagnosis of the disease. Furthermore, we hypothesize that miRNA detection in PC patients will yield prognostic information and help predict the response to treatment.
- 0 views
- 05 Aug, 2020
Clinical and Psycho-social Impact of COVID-19 Related Confinement on Patients With Digestive Tumors
A special focus is made on quality of life and psycho-social impact of treatment modifications on patients diagnosed with metastatic colorectal cancer and metastatic pancreatic cancer.
- 0 views
- 16 Feb, 2024
- 3 locations
Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC
Using the highly specialized, structure-sensitive methods of chiroptical spectroscopy (electronic circular dichroism - ECD, Raman optical activity - ROA) combined with conventional infrared (IR) and Raman spectroscopy, the first pilot studies yielded promising results with respect to the identification of spectral markers for pancreatic cancer, colon cancer and type 1 …
- 0 views
- 16 Feb, 2024
- 1 location
Determination of Blood Tumor Cells
Magnetic nanoparticles coated with anti-EpCAM or anti-CD52 antibodies will be tested ex-vivo in patients blood .
- 0 views
- 16 Feb, 2024
- 1 location